Novel Approaches and Challenges in Advancing Molecules into the Clinic
The Oncology Stream at PEGS Boston 2025 brings together three cutting-edge programs focused on revolutionizing cancer treatment. The Antibodies for Cancer Therapy conference explores innovative approaches in antibody-based treatments, design and optimization of new constructs, as well as lessons learned from successes and failures in the field. The Emerging Targets for Oncology & Beyond conference delves into novel target discovery and validation, leveraging AI, and exploring the microbiome and tumor microenvironment. Finally, the Driving Clinical Success in Antibody-Drug Conjugates conference showcases advancements in ADC design, featuring novel payloads and engineering strategies to enhance efficacy and overcome resistance. Collectively, these conferences address the exciting next wave in antibody therapeutics. By bringing together world-class researchers, clinicians, and industry experts, this stream aims to accelerate breakthroughs in cancer treatment, fostering collaboration and driving innovation in personalized medicine and targeted therapies.
Conferences Include:
May 12-13
Antibodies for Cancer Therapy
May 13-14
Emerging Targets for Oncology and Beyond
May 15-16
Driving Clinical Success in Antibody Drug Conjugates